Related Topics News -

     
 Title only   |   Print 
     
《大行》高盛:康哲藥業上半年收入增長放緩惟盈利韌性強 目標價下調至17.96元評級「買入」

2026-08-19T  
《業績》康哲藥業中期純利9.86億人民幣升4.8% 派息16.34分

2026-08-17T  
康哲藥業CMS-D017膠囊獲中國簽發藥物臨床試驗批准通知書

2026-07-16T  
英矽智能升逾半成 與康哲藥業達成中樞神經藥物研發合作

2026-07-13T  
英矽智能與康哲藥業達成中樞神經藥物研發合作

2026-07-13T  
康哲藥業自主研發INHBE小核酸藥物CMS-D008亮相ADA大會

2026-06-09T  
康哲藥業創新藥CMS-D001片獲內地同意開展臨床試驗

2026-05-26T  

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.